Cell survival pathways targeted in rare lung disease affecting women.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37163598.
- Also identified by DOI 10.1126/sciadv.adi1215 and PMC identifier 10171799.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.
Medical subject headings
- Lymphangioleiomyomatosis
- Lung Neoplasms